Cultivation Capital Life Sciences Fund II, LLC
Built from the SEC filing index the day the filing landed. The figures below are the issuer's own from Form D; AltStreet's analysis, sponsor link and data flags follow when the entity is enriched.
Raised
$19M
Investors
54
Min Invest
$100,000
What this filing shows
·Every sentence is a value as filed on SEC Form D
Cultivation Capital Life Sciences Fund II, LLC is a Delaware limited liability company that first filed a Form D on November 1, 2016 and most recently amended it on May 15, 2020, describing itself as a venture capital fund. The offering claims Rule 506(b), Section 3(c), Section 3(c)(1) and covers pooled investment fund interests. Cultivation Capital Life Sciences Fund II, LLC reported $19,175,000 sold from 54 investors of a $30,000,000 total offering as of the Form D filed May 15, 2020. The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. Because the fund also relies on Section 3(c)(1), it may have no more than 100 beneficial owners. The filing reports no non-accredited investors. The minimum investment accepted from an outside investor is $100,000. The Form D names no recipient of sales compensation, which usually means the issuer or its affiliates are placing the securities directly. The issuer's address of record is 911 Washington Avenue, Suite 801, St. Louis, MO 63101.
Critical Disclosures
What the filings and the regulators have said about this entity that a reader should know first. Each line links to its source. The history, the same event across other issuers, and alerts are in the terminal.
Reporting lapsed · Form D · last filing May 15, 2020
Offering declared to continue beyond a year; annual amendment 13+ months overdue An issuer that stops filing is the case the going-concern flag cannot catch: the report that would have carried it was never filed.
EDGAR Filing Data
Form D — Primary Source
View on SEC.govFilings on Record
Every filing AltStreet's ledger holds for this CIK, newest first. Each opens the SEC archive folder.
Fund Family
Every vehicle in this manager's series as it appears on EDGAR, newest generation first. Sold-to-date and investor counts are each vehicle's latest Form D.
Fund family
Cultivation Capital Life Sciences Fund2 vehicles · 2 generations · since 2016 · $25.7M sold across the family
This issuer is in Fund II
| Vehicle | Role | First filed | Status | Sold | Investors |
|---|---|---|---|---|---|
| Fund IV · first filed 2025-04-02 · 1 vehicle · $6.5M sold | |||||
| Cultivation Capital Life Sciences Fund IV, LP | 2025-04-02 | raising | $6.5M | 0 | |
| Fund II · first filed 2016-11-01 · 1 vehicle · $19.2M sold · 54 investors | |||||
| Cultivation Capital Life Sciences Fund II, LLCthis issuer | 2016-11-01 | dark | $19.2M | 54 | |
Grouped from Form D issuer names (generation, sleeve, jurisdiction and legal-form tokens removed); a name-only match, so abbreviated or renamed vehicles can be missed. Sold and investor figures are each vehicle's latest Form D; sleeves that report the same figure share one family-wide total and are counted once. Performance lines are what a public pension plan reports for its own interest in that fund, net, on the plan's cash flows and valuation date; they are not the general partner's figures.
In the Terminal
Filing events
0
none on file
Critical / warning
0 / 0
0 watch · 0 info
Statements extracted
0
none on file
NAV prints
0
none on file
Offering chains
1
dark
Investor
- 1 offering timeline: velocity, share raised, first-sale lag, stalled flags
Pro
- This issuer against its cohort: rank by velocity and share raised among offerings filed the same quarter
- The same events, statements and NAV moves across every issuer, screenable, with unlimited watches and CSV
Counts and dates above are the free record. The values, the series and the comparisons are the seat. Loading your view…
Adviser of Record (Form ADV)
CRD 168734 · SEC-registered adviser · lists this fund on Schedule D 7.B.(1) as a venture capital fund
From the adviser's Form ADV as loaded from the SEC bulk data through December 31, 2024, joined on this issuer's Form D file number. Fund-level figures and the adviser's full fund roster are in the terminal.
Related Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
Cultivation Capital Life Sciences Fund II Manager, LLC
Executive Officer · St. Louis, MO
The issuer's manager
William R. Schmidt
Executive Officer, Director, Promoter · St. Louis, MO
Manager of Cultivation Capital Life Sciences Fund II Manager, LLC, the issuer's manager, and managing director of the issuer
David A. Smoller
Executive Officer, Director, Promoter · St. Louis, MO
Managing director of the issuer
Rick L. Ryan
Executive Officer, Director, Promoter · St. Louis, MO
Managing director of the issuer
Bobby W. Sandage
Executive Officer, Director, Promoter · St. Louis, MO
Managing director of the issuer
Questions About Cultivation Capital Life Sciences Fund II, LLC
Each answer is built from the values on the SEC filing and the AltStreet ledger, not from the issuer's marketing.
What is Cultivation Capital Life Sciences Fund II, LLC?
Cultivation Capital Life Sciences Fund II, LLC is a Delaware limited liability company that filed a Form D with the SEC on May 15, 2020 as a venture capital fund. The filing claims Rule 506(b), Section 3(c), Section 3(c)(1) for an offering of pooled investment fund interests.
Is Cultivation Capital Life Sciences Fund II, LLC legit?
AltStreet does not rate legitimacy; it reports the public record. Cultivation Capital Life Sciences Fund II, LLC filed a Form D with the SEC on May 15, 2020 claiming Rule 506(b), Section 3(c), Section 3(c)(1). A Form D is a notice of an exempt offering, not a review or approval of it. The newest notice reports $19,175,000 sold to 54 investors. AltStreet's enforcement record (SEC, FINRA and state actions) shows no action naming the issuer as of today. Before investing, confirm the filing on EDGAR, check the seller's registration on FINRA BrokerCheck, and read the offering documents, which a Form D does not include.
Is Cultivation Capital Life Sciences Fund II, LLC registered with or approved by the SEC?
No. A Form D is a notice that an issuer is selling securities under an exemption from registration, and the SEC does not review, approve, or pass on the merits of the offering. The filing shows that Cultivation Capital Life Sciences Fund II, LLC claimed Rule 506(b), Section 3(c), Section 3(c)(1) and disclosed the items the form requires, such as the amount sold, the minimum investment, related persons, and anyone paid to sell the securities. It does not verify the issuer's claims or its business.
How much has Cultivation Capital Life Sciences Fund II, LLC raised?
Cultivation Capital Life Sciences Fund II, LLC reported $19,175,000 sold from 54 investors of a $30,000,000 total offering as of the Form D filed May 15, 2020.
Who can invest in Cultivation Capital Life Sciences Fund II, LLC?
The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. Because the fund also relies on Section 3(c)(1), it may have no more than 100 beneficial owners. The filing reports no non-accredited investors. The minimum investment accepted from an outside investor is $100,000.
What is the minimum investment in Cultivation Capital Life Sciences Fund II, LLC?
The Form D lists $100,000 as the minimum investment accepted from any outside investor as of May 15, 2020. Issuers can waive their own minimums, and the figure does not include fees.
Who is selling Cultivation Capital Life Sciences Fund II, LLC and how are they paid?
The Form D names no recipient of sales compensation, which usually means the issuer or its affiliates are placing the securities directly.
Who is behind Cultivation Capital Life Sciences Fund II, LLC?
The Form D lists 5 related persons: Cultivation Capital Life Sciences Fund II Manager, LLC, executive officer (The issuer's manager); William R. Schmidt, executive officer, director, promoter (Manager of Cultivation Capital Life Sciences Fund II Manager, LLC, the issuer's manager, and managing director of the issuer); David A. Smoller, executive officer, director, promoter (Managing director of the issuer); Rick L. Ryan, executive officer, director, promoter (Managing director of the issuer); Bobby W. Sandage, executive officer, director, promoter (Managing director of the issuer). Form D Item 3 requires executive officers, directors, and promoters of the issuer to be listed.
Where is Cultivation Capital Life Sciences Fund II, LLC located?
The issuer's address on its SEC filings is 911 Washington Avenue, Suite 801, St. Louis, MO 63101. Its phone number of record is 3147803013. It is organized under the laws of Delaware.
How long is the Cultivation Capital Life Sciences Fund II, LLC offering open?
The issuer indicated that the offering is intended to last more than one year. An issuer must amend its Form D annually while a continuing offering stays open; 3 amendments are on record for this CIK.
How large is Cultivation Capital Life Sciences Fund II, LLC?
The Form D reports a revenue range of Not Applicable.
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.